Search

Search Constraints

You searched for: Author/Creator Kouanfack, Charles

Search Results

1. Addition of Flucytosine to Fluconazole for the Treatment of Cryptococcal Meningitis in Africa: A Multicountry Cost-effectiveness Analysis. (28th February 2019)

2. Comparative Immunovirological and Clinical Responses to Antiretroviral Therapy Between HIV-1 Group O and HIV-1 Group M Infected Patients. (7th May 2019)

4. Cryptococcus neoformansisolates from Yaoundé human immunodeficiency virus‐infected patients exhibited intra‐individual genetic diversity and variation in antifungal susceptibility profiles between isolates from the same patient. Issue 7 (July 2016)

5. Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in Cameroon. Issue 10 (October 2020)

6. Efficacy and safety of three second-line antiretroviral regimens in HIV-infected patients in Africa. (31st July 2015)

7. Fungal Burden and Raised Intracranial Pressure Are Independently Associated With Visual Loss in Human Immunodeficiency Virus-Associated Cryptococcal Meningitis. (5th February 2021)

8. Gender Differences in Adherence and Response to Antiretroviral Treatment in the Stratall Trial in Rural District Hospitals in Cameroon. (1st July 2015)

9. Genetic diversity of the Hwp1 gene and HIS3, EF3, CDC3 microsatellites and antifungal susceptibility profiles of Candida albicans isolates from Yaoundé HIV-infected patients. (15th October 2016)